Publicaciones en colaboración con investigadores/as de University of Paris-Saclay (27)

2024

  1. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71

  2. Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey

    Infection

2023

  1. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

    International Journal of Infectious Diseases, Vol. 137, pp. 98-110

  2. Editorial: New-generation vaccines and novel vaccinal strategies against infectious diseases of livestock, wild and companion animals

    Frontiers in Immunology

  3. Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey

    Blood Advances, Vol. 7, Núm. 11, pp. 2645-2655

  4. Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma

    Liver International, Vol. 43, Núm. 12, pp. 2776-2793

  5. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors

    Cancer research, Vol. 83, Núm. 2, pp. 239-250

2022

  1. Bona fide atypical scrapie faithfully reproduced for the first time in a rodent model

    Acta Neuropathologica Communications, Vol. 10, Núm. 1

2021

  1. Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues

    European Journal of Medicinal Chemistry, Vol. 223

  2. Association of the lung immune prognostic index with immunotherapy outcomes in mismatch repair deficient tumors

    Cancers, Vol. 13, Núm. 15

  3. Astrocyte-neuron metabolic cooperation shapes brain activity

    Cell Metabolism, Vol. 33, Núm. 8, pp. 1546-1564

  4. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

    The Lancet Oncology, Vol. 22, Núm. 4, pp. 463-475

  5. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

    The Lancet Oncology, Vol. 22, Núm. 5, pp. 727-736

  6. Endoglin is an endothelial housekeeper against inflammation: Insight in ECFC-related permeability through LIMK/cofilin pathway

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  7. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  8. L-Serine links metabolism with neurotransmission

    Progress in Neurobiology, Vol. 197

  9. Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19

    New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802

2020

  1. A missense in HSF2BP causing primary ovarian insufficiency affects meiotic recombination by its novel interactor c19orf57/brme1

    eLife, Vol. 9, pp. 1-93

  2. Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region with Cortical and Subcortical Morphology and Cognition

    JAMA Psychiatry, Vol. 77, Núm. 4, pp. 420-430

  3. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia

    Molecular Psychiatry, Vol. 25, Núm. 3, pp. 584-602